Skip to main content

Part of UT Health San Antonio

Graduate School of Biomedical Sciences, UT Health San AntonioGraduate School of Biomedical Sciences, UT Health San Antonio

Part of UT Health San Antonio

Give
Search

Quicklinks

Commencement

  • Commencement 2021

Logins

  • Canvas
  • CourseLeaf
  • IMPACT
  • LiveMail
  • My UT Health (Intranet)

Resources

  • COVID-19 Updates for Students
  • Enrolled Student Resources
  • Educational Resources
  • GSBS Data Request Form

 Close Quicklinks

 
Menu
  • About
  • Admissions
  • Programs
  • Research
  • Faculty
  • Student Life
  • Alumni

You are here

  • Faculty directory
  • Aguiar, Ricardo C.
Ricardo Aguiar

Contact

210-567-4860

aguiarr@uthscsa.edu

Programs

M.D./Ph.D. in South Texas Medical Scientist Training Program
Molecular Immunology & Microbiology
Ph.D. in Integrated Biomedical Sciences

Departments & Divisions

Department of Medicine
Division of Hematology & Oncology

Institutes and Centers

  • Mays Cancer Center

Research

Researcher profile

Ricardo Aguiar, M.D., Ph.D.

Professor of Medicine

Biochemistry

Microbiology, and Immunology

Lymphoma Biology

BCR signaling, transcription factor deregulation, and mitochondrial metabolism

Our group focus is on the identification and functional characterization of the genetic abnormalities of hematologic malignancies. We utilize in vitro and in vivo systems, in genome-wide or targeted studies, with the intent of translating these discoveries into clinical initiatives. The principal disease model in our lab is B-cell lymphoma. Active research lines stem from our recently published work and include: 1) The intersection between B-cell receptor signaling and phosphodiesterase 4 (PDE4) as actionable therapeutic targets in mature B cell malignancies; 2) Metabolic imbalance and epigenetic reprogramming in lymphomas; 3) Transcription factor IRF8 and lymphomagenesis.

Related diseases: B cell lymphomas, lymphoid leukemias

Techniques: Genetic modification of cancer cells in vitro using retrovirus and lentivirus, genetic engineering of mouse models, in vivo (mouse) manipulations, multiple signaling assays, genome-wide analysis (DNA, RNA, and protein) of primary human tumors 

  • Professional Background

    Education

    • 1998 - Postdoctoral Fellowship - Lymphoma Biology - Harvard Medical School
    • 1996 - Postdoctoral Fellowship - Leukemia Biology - Centre for Adult Leukaemia, Hammersmith Hospital, University of London
    • 1994 - PhD - Leukemia Biology (Magna Cum Laude) - University of Sao Paulo, School of Medicine
    • 1992 - Clinical Fellowship - Hematology & Oncology - Hospital das Clinicas, School of Medicine, University of Sao Paulo
    • 1990 - Residency - Internal Medicine - Hospital das Clinicas, School of Medicine, University of Sao Paulo
    • 1988 - MD - Medicine - Federal University of Paraiba

    Appointments

    • 1998 - 2005 - Instructor in Medicine - Harvard Medical School, Boston, MA
    • 2005 - 2010 - Assistant Professor in Medicine and Biochemistry - UT Health San Antonio
    • 2012 - 2019 - Associate Director South Texas MSTP (MD/PhD) Program - UT Health San Antonio
    • 2010 - 2015 - Associate Professor in Medicine and Biochemistry (tenured in 2012) - UT Health San Antonio
    • 2015 - Present - Professor in Medicine, Biochemistry and Immunology (tenured) - UT Health San Antonio
    • 2019 - Present - Vice Chief for Research - Division of Hematology/Med Oncology - UT Health San Antonio
    • 2015 - Present - UT Health San Antonio
    • 2019 - Present - Vice Chief for Research - Division of Hematology/Med Oncology - UT Health San Antonio
  • Instruction & Training

    • 2005 - Present, Post-Doctoral Student Supervision, UTHSA
    • 2010 - Present, Junior Faculty Supervision, UTHSA
    • Post-Doctoral Student Supervision, UTHSCSA
    • 2/2011 - Present, Individual Instruction, UTHSCSA
    • 2005 - Present, Post-Doctoral Student Supervision, UTHSA
    • 2010 - Present, Junior Faculty Supervision, UTHSA
  • Research & Grants

    • BX001882-09 VA Merit Award (PI -Aguiar)

    04/2022 - 03/2026

    Title: Post-translation control of TET function in lymphoma

     

    • R01ES031522 - NIH/NIES (PI – Aguiar)

    04/2020 - 03/2025

    Title: Oxidative stress and RNA methylation

     

    • R01GM140456 - NIH/NIGMS (PI- Aguiar)

    01/2021 - 12/2024

    Title: Mitochondrial 2-hydroxyglutarate dehydrogenases modulate the cellular epitranscriptome

    Research profile

  • Publications

    Journal Article

    Ortega M, Bhatnagar H, Lin AP, Wang L, Aster JC, Sill H, Aguiar RC. A microRNA-mediated regulatory loop modulates NOTCH and MYC oncogenic signals in B and T cell malignancies Leukemia 2014 Oct;. Cheah CY, Burbury K, Apperley JF, Huguet F, Pitini V, Gardembas M, Ross DM, Forrest D, Genet P, Rousselot P, Patton N, Smith G, Dunbar CE, Ito S, Aguiar RC, Odenike O, Gimelfarb A, Cross NC, Seymour JF. Patients with myeloid malignancies bearing PDGFRB fusion genes achieve durable long-term remissions with imatinib Blood 2014 Jun;123(23):3574-3577.

Map image of UT Health San Antonio location
UT Health San Antonio
Graduate School of Biomedical Sciences

7703 Floyd Curl Drive

San Antonio, TX 78229

210-567-3709

gsbs@uthscsa.edu

  • About us
  • Contact us
  • Maps & directions

We make lives better ®

The University of Texas Health Science Center at San Antonio, also called UT Health San Antonio, is a leading academic health center with a mission to make lives better through excellence in advanced academics, life-saving research and comprehensive clinical care including health, dental and cancer services.

Web Privacy | Links from websites affiliated with UT Health's website (uthscsa.edu) to other websites do not constitute or imply university endorsement of those sites, their content, or products and services associated with those sites. The content on this website is intended to be used for informational purposes only. Health information on this site is not meant to be used to diagnose or treat conditions. Consult a health care provider if you are in need of treatment.